Contact
searchSearch
HMP Global

Innovations in IO Topic Center

Featured

Dr. David Breen and Dr. Maxine Tran
Video
Partnership of Interventional Radiology and Urology in the Treatment of RCC
09/01/2023
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David...
09/01/2023
IO Learning
IO 'Unmasked' Yolanda Bryce MD
Interview
IO ‘Unmasked’: An Interview With Dr. Yolanda Bryce
08/24/2023
Elizabeth Blackwell, the first woman doctor in modern times, once said, “It is not easy to be a pioneer – but oh, it is fascinating!” In the interventional oncology field, there are many pioneering women that strive daily to form a brighter...
Elizabeth Blackwell, the first woman doctor in modern times, once said, “It is not easy to be a pioneer – but oh, it is fascinating!” In the interventional oncology field, there are many pioneering women that strive daily to form a brighter...
Elizabeth Blackwell, the first...
08/24/2023
IO Learning
Dr. Solomon Dr. Elsayed Future of IO
Interview
The Future of IO: Embracing the ‘Pioneer Spirit’ of Innovative Cancer Care
08/22/2023
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology...
08/22/2023
IO Learning
Dr. Kirema Garcia-Reyes, Dr. Yolanda Bryce, Dr. Leigh Casadaban, Yixuan Yuki Ji, Samantha Hager
Video
DEI in Interventional Oncology and Radiology
07/11/2023
A Panel With Yixuan Yuki Ji, Dr. Casadaban, Dr. Garcia-Reyes, and Dr. Bryce discussing some of the major equity topics in IO and how representation and a level of deep understanding of different cultures can benefit patients, data accuracy,...
A Panel With Yixuan Yuki Ji, Dr. Casadaban, Dr. Garcia-Reyes, and Dr. Bryce discussing some of the major equity topics in IO and how representation and a level of deep understanding of different cultures can benefit patients, data accuracy,...
A Panel With Yixuan Yuki Ji, Dr....
07/11/2023
IO Learning
Dr. AJ Gun, Dr. Christopher Malone
Podcast
Award-Winning Abstract From SIO 2023
06/30/2023
Dr Gunn and Dr Malone discuss Dr. Malone’s Award-Winning abstract from SIO 2023, the process of actualizing this study, and what to expect from Dr. Malone and his colleagues at SIO 2024.
Dr Gunn and Dr Malone discuss Dr. Malone’s Award-Winning abstract from SIO 2023, the process of actualizing this study, and what to expect from Dr. Malone and his colleagues at SIO 2024.
Dr Gunn and Dr Malone discuss...
06/30/2023
IO Learning
Dr. Wylie Foss, MD, Dr. Steven Yevich, MD
Practical Tips and Tricks
Transvertebral Access for Ablation of Metastasis Located Anterior to the Spine
06/30/2023
This case report and review highlights the case of a 45-year-old woman was diagnosed with stage IV sigmoid colon adenocarcinoma. Dr. Wylie Foss and Dr. Steven Yevich share their insights into transvertebral access for ablation of metastasis...
This case report and review highlights the case of a 45-year-old woman was diagnosed with stage IV sigmoid colon adenocarcinoma. Dr. Wylie Foss and Dr. Steven Yevich share their insights into transvertebral access for ablation of metastasis...
This case report and review...
06/30/2023
IO Learning
Govindarajan Narayanan, MD
Podcast
First Liver Cancer Patient Treatment Using Epione Robot in the US: An Interview with Govindarajan Narayanan, MD
06/16/2023
Dr Govindarajan Narayanan discusses his recent outstanding achievement of successfully treating the first patient in the United States with a liver tumor using Quantum Surgical’s Epione robot.
Dr Govindarajan Narayanan discusses his recent outstanding achievement of successfully treating the first patient in the United States with a liver tumor using Quantum Surgical’s Epione robot.
Dr Govindarajan Narayanan...
06/16/2023
IO Learning
News
Immunophotonics Announces 1st Patient Dosed in Multinational Clinical Trial in the United Kingdom
06/02/2023
Saint Louis, MO | Bern, Switzerland (2 June 2023) — Immunophotonics Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the recruitment and the dosing of its first...
Saint Louis, MO | Bern, Switzerland (2 June 2023) — Immunophotonics Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the recruitment and the dosing of its first...
Saint Louis, MO | Bern,...
06/02/2023
IO Learning
News
The Future of Bleeding Control: Obsidio Conformable Embolic
05/22/2023
Marlborough, MA (17 May 2023) –Suppose you’re a doctor who needs to stop blood flow in a patient. Maybe it’s a patient with internal bleeding after an accident. Perhaps it’s to starve the blood supply of a patient’s cancerous tumor...
Marlborough, MA (17 May 2023) –Suppose you’re a doctor who needs to stop blood flow in a patient. Maybe it’s a patient with internal bleeding after an accident. Perhaps it’s to starve the blood supply of a patient’s cancerous tumor...
Marlborough, MA (17 May...
05/22/2023
IO Learning
Dr Alan Sag
SIO2023 Highlights
Current Trends and Future Directions in Musculoskeletal Interventions
01/20/2023
Alan Alper Sag, MD, Assistant Professor, Duke Interventional Radiology and Duke Orthopaedic Surgery, discusses the current state and future of musculoskeletal interventions.
Alan Alper Sag, MD, Assistant Professor, Duke Interventional Radiology and Duke Orthopaedic Surgery, discusses the current state and future of musculoskeletal interventions.
Alan Alper Sag, MD, Assistant...
01/20/2023
IO Learning
Dr Alan Alper Sag
Podcast
Salvage Cryoablation for Local Recurrences of Thyroid Cancer
11/30/2022
Dr Sag discusses his recent JVIR article, "Salvage Cryoablation for Local Recurrences of Thyroid Cancer Inseparable from the Trachea and Neurovascular Structures" and offers helpful tips on practice-building in this domain.
Dr Sag discusses his recent JVIR article, "Salvage Cryoablation for Local Recurrences of Thyroid Cancer Inseparable from the Trachea and Neurovascular Structures" and offers helpful tips on practice-building in this domain.
Dr Sag discusses his recent JVIR...
11/30/2022
IO Learning

Presentations

Dr de Baere
Human Intratumoral Injections: Rationale and Technique
02/08/2022
Dr Chick
Endoscopy in Image-Guided Interventions for the IO/IR
02/08/2022
Dr Alban
Inadequate Future Liver Remnant: Hepatic Venous Deprivation with Simultaneous Portal Vein Embolization and Hepatic Vein Embolization
02/08/2022
Dr Raj
Pancreas: Irreversible Electroporation (IRE)
02/08/2022
Dr de Baere
Local Immunotherapy: The Role of IR
02/08/2022
Dr Bryce
Locoregional Treatment of Breast Cancer
02/08/2022
Dr Afshin Gangi
Interventional Neuro-Oncology: The Next Frontier
02/08/2022
Dr Bhatia
IR in Prostate Cancer
02/08/2022
My Approach to Metastatic Breast Cancer
02/04/2022
My Approach to Metastatic Colorectal Cancer
02/04/2022
Dr. David S. Wang
CIO Presentation
HCC: Year in Review With Dr. David S. Wang
11/09/2023
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang,...
11/09/2023
IO Learning
Callstrom CIO
Musculoskeletal Oncologic Interventions: 2022 Year in Review
Matthew Callstrom, MD, PhD presents notable 2022 studies on musculoskeletal interventions at the Symposium on Clinical Interventional Oncology.
01/06/2023
Ahmed CIO Video
Renal Ablation: 2022 Year in Review
Muneeb Ahmed, MD, FSIR presents notable 2022 studies on renal ablation at the Symposium on Clinical Interventional Oncology.
01/06/2023
Robert Suh
Lung Ablation: 2022 Year in Review
Robert Suh, MD presents notable 2022 studies on lung ablation at the Symposium on Clinical Interventional Oncology.
01/06/2023
Ganguli CIO
Y90 Update on Metastatic Disease: 2022 Year in Review
Suvranu Ganguli, MD, FSIR presents notable 2022 studies on Y-90 for metastatic disease at the Symposium on Clinical Interventional Oncology.
01/06/2023
Tabori CIO
Y90: 2022 Year in Review
Nora Tabori, MD presents notable Y-90 studies at the Symposium on Clinical Interventional Oncology in 2022.
01/06/2023
Dan Brown
Liver Metastatic Disease: 2022 Year in Review
Daniel Brown, MD, FSIR reviews noteworthy 2022 studies on liver metastatic disease at the Symposium on Clinical Interventional Oncology.
01/04/2023
Riad Salem, MD, MBA
HCC: 2022 Year in Review
Riad Salem, MD, MBA presents notable studies from 2022 at the Symposium on Clinical Interventional Oncology.
01/01/2023
Dr Abdel Aal
HCC Treatment Complicated by Pneumothorax
02/17/2022
Dr Prologo
Cement Placement Complicated by Extra Vertebral Body
02/17/2022

Abstracts

CIO 2022-4 Preoperative Endovascular Embolization of Intracranial Meningiomas
Purpose: The purpose is to report on technical considerations involved in preoperative embolization of intracranial meningiomas. We present four cases to highlight the associated vascular...
10/18/2022
CIO 2022-12 Uterine Artery Embolization in the Treatment of Postpartum Uterine Hemorrhage: A Single-Center Experience in India
Purpose: To evaluate the clinical effectiveness and safety of uterine artery embolization (UAE) in the treatment of patients with primary postpartum hemorrhage (PPH), secondary PPH, and P...
10/18/2022
CIO 2022-13 Role of Embolization in Acquired Uterine Vascular Malformations: A Single-Center Study in India
Purpose: To determine the efficacy of uterine artery embolization (UAE) in patients with bleeding acquired uterine arteriovenous malformations (AVMs).
10/18/2022
CIO 2022-15 Uterine Artery Embolization: An Interventional Aid
Purpose: Fibroids are the commonest benign lesions of the uterus. They present with bleeding per vagina in majority of the cases. Surgical treatment consists of hysterectomy or myomectomy...
10/18/2022
CIO 2022-17 Preoperative Embolization in Carotid Body Tumors: A Single-Center Experience in India
Purpose: The purpose of this study is to compare the efficiency of preoperative embolization on vascular rupture rates during surgery in 260 patients within two groups.
10/18/2022
CIO 2022-18 Role of Splenic Artery Embolization in the Management of Various Splenic Pathologies
Purpose: To evaluate technical and clinical success, complications of splenic artery embolization in management of different splenic pathologies.
10/18/2022
CIO 2022-19 Embolization of the Lingual Artery in Transoral Robotic Surgery for Management of Recurrent Tongue Carcinomas
Purpose: The incidence of oropharyngeal carcinoma has been on the rise in recent decades. About 30% of patients who undergo definitive chemoradiation as the initial treatment present with...
10/18/2022
CIO 2021-7 Recent Advances and Future Directions in Locoregional Therapy for Colorectal Cancer with Liver Metastasis
Purpose: Colon cancer is the third most common cancer worldwide, and half of patients with colon cancer will develop liver metastasis. In the past decade, a number of locoregional approac...
11/15/2021
CIO 2021-8 Selective Internal Radiation Therapy of Metastatic Breast Cancer to the Liver: A Meta-analysis
Purpose: To conduct a meta-analysis to assess the safety and efficacy of yttrium-90 transarterial radioembolization (TARE) in treating breast cancer patients with hepatic metastasis ...
11/15/2021
CIO 2021-9 Efficacy of prostate artery embolization in low and high risk prostate cancer patients
Purpose: Patients diagnosed with prostate cancer (PCa) are usually put into low and high risk groups. Patients in the low risk category often have a choice of undergoing Active Surveillan...
11/15/2021
Ebstesam Nafie
CIO2023 Highlights
A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields
12/14/2023
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her...
12/14/2023
IO Learning
Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture
CIO2023 Highlights
Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-30 Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture."
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-30 Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture."
Hanna Thompson discusses her...
11/30/2023
IO Learning
Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck
CIO2023 Highlights
Thyroid Ablation After Thyroid Cancer Recurrence in a Hostile Neck
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-31 Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck ."
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-31 Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck ."
Hanna Thompson discusses her...
11/30/2023
IO Learning
Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites
CIO2023 Highlights
Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites."
Hanna Thompson discusses her CIO2023 abstract, "Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites."
Hanna Thompson discusses her...
11/30/2023
IO Learning
Brendan Ryu
CIO2023 Highlights
Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review
11/14/2023
Brendan Ryu discusses his CIO2023 abstract, "CIO 2023-23 Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review ."
Brendan Ryu discusses his CIO2023 abstract, "CIO 2023-23 Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review ."
Brendan Ryu discusses his...
11/14/2023
IO Learning
Ashwin Mahendra
CIO2023 Highlights
Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia
11/13/2023
Ashwin Mahendra discusses his CIO2023 abstract, "CIO 2023-35 Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia."
Ashwin Mahendra discusses his CIO2023 abstract, "CIO 2023-35 Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia."
Ashwin Mahendra discusses his...
11/13/2023
IO Learning
CIO 2023-34 Radioembolization Plus Gemcitabine, Cisplatin, and Capecitabine as First-Line Therapy for Intrahepatic Cholangiocarcinoma
Purpose: To report outcomes of an institutional downstaging protocol for intrahepatic cholangiocarcinoma (iCCA) using radioembolization (TARE), gemcitabine, cisplatin, and capecitabine co...
11/02/2023
CIO 2023-33 Tumor Size and Watershed Area Correlates in Progression of Hepatocellular Carcinoma after Segmental Radioembolization
Purpose: To identify factors of incomplete treatment after segmental transarterial radioembolization (TARE) for treatment-naïve and solitary hepatocellular carcinoma (HCC)
11/02/2023
CIO 2023-32 Transradial versus Transfemoral Access for Interventional Oncology Procedures: A Systematic Review and Meta-Analysis
Purpose: The procedural and clinical outcomes of a transradial approach (TRA) versus a transfemoral approach (TFA) for interventional oncology (IO) procedures remain unclear.
11/02/2023
CIO 2023-26 The Cost of Catheter Dislodgement
Purpose: Long term care of patient's with complicated disease processes often incurs significant financial burden. This burden if often complicated with misuse or failure of medical devic...
11/02/2023

Interviews

Dr. David Breen and Dr. Maxine Tran
Video
Partnership of Interventional Radiology and Urology in the Treatment of RCC
09/01/2023
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David...
09/01/2023
IO Learning
Dr. Solomon Dr. Elsayed Future of IO
Interview
The Future of IO: Embracing the ‘Pioneer Spirit’ of Innovative Cancer Care
08/22/2023
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology...
08/22/2023
IO Learning
Interview
Phase I First-in-Human Study on the Use of Embrace Liquid Embolic for the Treatment of Hypervascular Tumors
06/14/2022
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S....
06/14/2022
IO Learning
Dr Tomkovich
Podcasts
Interview With Dr Kenneth Tomkovich: ICE3 Trial 3-Year Interim Results
10/20/2021
The ICE3 trial was designed to evaluate the safety and efficacy of breast cryoablation in women older than 60 years with low-risk early-stage breast cancers. Dr Kenneth Tomkovich, co-principal investigator of ICE3, joined us to discuss the...
The ICE3 trial was designed to evaluate the safety and efficacy of breast cryoablation in women older than 60 years with low-risk early-stage breast cancers. Dr Kenneth Tomkovich, co-principal investigator of ICE3, joined us to discuss the...
The ICE3 trial was designed to...
10/20/2021
IO Learning
Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
Addition of Durvalumab, Bevacizumab to TACE for Hepatocellular Carcinoma Improves PFS
01/23/2024
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
Interview
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
12/08/2023
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview,...
12/08/2023
IO Learning
Dr. Riad Salem
Interview
Redefining the ‘Status Quo’ of IO
12/07/2023
In this interview with Riad Salem, MD, Chief of Vascular and Interventional Radiology in the Department of Radiology at Northwestern Medicine, we discuss the future of IO, unique approaches to Y-90, and what's next for the interventional...
In this interview with Riad Salem, MD, Chief of Vascular and Interventional Radiology in the Department of Radiology at Northwestern Medicine, we discuss the future of IO, unique approaches to Y-90, and what's next for the interventional...
In this interview with Riad...
12/07/2023
IO Learning
Dr. Edward Kim
CIO2023 Highlights
HCC, Flow-Diversion, and IO Outpatient Labs with Dr. Edward Kim
12/06/2023
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr....
12/06/2023
IO Learning
Dr. AJ Gunn Unmasked
Interview
IO ‘Unmasked’: An Interview With Dr. AJ Gunn
11/07/2023
In this interview, Dr. AJ Gunn shares insights and lessons about his profession and passions.
In this interview, Dr. AJ Gunn shares insights and lessons about his profession and passions.
In this interview, Dr. AJ Gunn...
11/07/2023
IO Learning
Dr. Ripal Gandhi HCC
Interview
Locoregional Therapies and High Lung Shunts: An HCC Highlight With Dr. Ripal Gandhi
10/25/2023
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM,...
10/25/2023
IO Learning
Dr. David Breen and Dr. Maxine Tran
Video
Partnership of Interventional Radiology and Urology in the Treatment of RCC
09/01/2023
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David...
09/01/2023
IO Learning
Dr. Solomon Dr. Elsayed Future of IO
Interview
The Future of IO: Embracing the ‘Pioneer Spirit’ of Innovative Cancer Care
08/22/2023
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology...
08/22/2023
IO Learning
Jeff Elton Dan McSweeney ConcertAI
Interview
'AI-vengers Assemble': Extending Lives, Embracing Equity, and Eliminating Burnout With Intelligent Data
06/06/2023
IO Learning spoke with Jeff Elton, President and CEO of ConcertAI, and Dan McSweeney, President of TeraRecon, the healthcare business unit of ConcertAI, to discuss how ConcertAI can help both IO professionals and their patients now and in the...
IO Learning spoke with Jeff Elton, President and CEO of ConcertAI, and Dan McSweeney, President of TeraRecon, the healthcare business unit of ConcertAI, to discuss how ConcertAI can help both IO professionals and their patients now and in the...
IO Learning spoke with Jeff...
06/06/2023
IO Learning
Interview
Building an Interventional Oncology Program With a Focus on Operational Efficiency and Exceptional Patient Care:
03/28/2023
Dr Kamel, interventional radiology section chief, was looking for a partner to help create his vision for the future, focused on growing the interventional oncology practice. In order to support this growth, he needed a partner who shared...
Dr Kamel, interventional radiology section chief, was looking for a partner to help create his vision for the future, focused on growing the interventional oncology practice. In order to support this growth, he needed a partner who shared...
Dr Kamel, interventional...
03/28/2023
IO Learning

Subscribe

IO Learning Newsletter

News

News
Immunophotonics Announces 1st Patient Dosed in Multinational Clinical Trial in the United Kingdom
06/02/2023
Saint Louis, MO | Bern, Switzerland (2 June 2023) — Immunophotonics Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the recruitment and the dosing of its first...
Saint Louis, MO | Bern, Switzerland (2 June 2023) — Immunophotonics Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the recruitment and the dosing of its first...
Saint Louis, MO | Bern,...
06/02/2023
IO Learning
News
The Future of Bleeding Control: Obsidio Conformable Embolic
05/22/2023
Marlborough, MA (17 May 2023) –Suppose you’re a doctor who needs to stop blood flow in a patient. Maybe it’s a patient with internal bleeding after an accident. Perhaps it’s to starve the blood supply of a patient’s cancerous tumor...
Marlborough, MA (17 May 2023) –Suppose you’re a doctor who needs to stop blood flow in a patient. Maybe it’s a patient with internal bleeding after an accident. Perhaps it’s to starve the blood supply of a patient’s cancerous tumor...
Marlborough, MA (17 May...
05/22/2023
IO Learning
News
Study Shows Promising Safety, Patient Outcomes Data for MRI-Guided Adaptive Radiation Therapy to Treat Pancreatic Cancer
11/21/2022
DETROIT (Nov. 21, 2022) – Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table...
DETROIT (Nov. 21, 2022) – Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table...
DETROIT (Nov. 21, 2022) –...
11/21/2022
IO Learning
News
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient
09/01/2022
GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications
GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications
GPX® Trial Completes Enrollment...
09/01/2022
IO Learning
News
HistoSonics Hits Pivotal Clinical Trial Milestone In #HOPE4LIVER Studies
06/03/2022
Company Continues to Build as It Prepares for FDA Submission and Clearance of Its Breakthrough Therapy
Company Continues to Build as It Prepares for FDA Submission and Clearance of Its Breakthrough Therapy
Company Continues to Build as It...
06/03/2022
IO Learning
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
News
Radiation Therapy May Be Potential Heart Failure Treatment
11/28/2023
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose...
11/28/2023
Cath Lab Digest
News
Canon Medical Introduces Alphenix Sky 12 HD Interventional System
09/12/2023
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) —...
09/12/2023
IO Learning
News
A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting
09/11/2023
New York, NY (11 September 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the details of an oral...
New York, NY (11 September 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the details of an oral...
New York, NY (11 September 2023)...
09/11/2023
IO Learning
News
Boston Scientific Receives 510(k) Clearance for Expanded Cryoablation System
08/25/2023
Marlborough, MA. (25 August 2023) — Boston Scientific has received 510(k) clearance for expanded indication of the VISUAL ICE cryoablation system. The clearance grants this device an indication expansion to now...
Marlborough, MA. (25 August 2023) — Boston Scientific has received 510(k) clearance for expanded indication of the VISUAL ICE cryoablation system. The clearance grants this device an indication expansion to now...
Marlborough, MA. (25 August...
08/25/2023
IO Learning
News
Delcath Systems Announces FDA Approval of HEPZATO KIT for the Treatment of Adult Patients With Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
08/21/2023
New York, NY. (21 August 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that today the US Food and Drug...
New York, NY. (21 August 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that today the US Food and Drug...
New York, NY. (21 August 2023)...
08/21/2023
IO Learning
News
HMP Global Earns Healthcare Industry Top Workplaces Award for Company Culture, Employee Satisfaction
08/18/2023
Malvern, PA (18 August 2023) — HMP Global, the leading omnichannel events and education company, is one of only 111 companies nationwide to earn a 2023 Healthcare Industry Top Workplaces award, its fifth award this year based on employee...
Malvern, PA (18 August 2023) — HMP Global, the leading omnichannel events and education company, is one of only 111 companies nationwide to earn a 2023 Healthcare Industry Top Workplaces award, its fifth award this year based on employee...
Malvern, PA (18 August 2023)...
08/18/2023
IO Learning
News
Siemens Healthineers Announces Partnership With SSM Health
08/14/2023
Erlangen, Germany (14 August 2023) —SSM Health and Siemens Healthineers have announced a new 10-year strategic partnership agreement focused on expanding access to high-quality care and training the next generation of health care...
Erlangen, Germany (14 August 2023) —SSM Health and Siemens Healthineers have announced a new 10-year strategic partnership agreement focused on expanding access to high-quality care and training the next generation of health care...
Erlangen, Germany (14 August...
08/14/2023
IO Learning
News
Interventional Oncology Accreditation Program IASIOS Continues to Reach new Heights
08/11/2023
Vienna, Austria (11 August 2023) — The only accreditation system of its kind has nearly tripled its network of esteemed interventional oncology centers worldwide since launching in 2021.The International Accreditation System...
Vienna, Austria (11 August 2023) — The only accreditation system of its kind has nearly tripled its network of esteemed interventional oncology centers worldwide since launching in 2021.The International Accreditation System...
Vienna, Austria (11 August 2023)...
08/11/2023
IO Learning
News
Accuray Receives FDA 510(k) Clearance for its VitalHold™ on the Radixact® System
08/10/2023
Madison, WI (10 August 2023) — Accuray Incorporated has announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VitalHold™* breast package on...
Madison, WI (10 August 2023) — Accuray Incorporated has announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VitalHold™* breast package on...
Madison, WI (10 August 2023)...
08/10/2023
IO Learning

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use